Clinical Trial Update: Olanzapine for the Prevention of Postoperative Nausea and Vomiting [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates the investigation of olanzapine for preventing postoperative nausea and vomiting; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Amani Hassan Abdel-Wahab | Conditions: Postoperative Nausea | Phase 1, Phase 2 | Status: COMPLETED